重度肥胖男女中「肥胖相关性腺功能障碍」的患病率及减重手术后缓解的系统综述与Meta分析
该系统综述与Meta分析检索PubMed与EMBASE截至2016年6月的文献,最终纳入29项研究,评估重度肥胖患者中肥胖相关gonadal功能障碍的患病率及减重手术后的缓解情况;女性多囊卵巢综合征患病率为36%,男性肥胖相关继发性性腺功能减退症为64%,术后缓解率分别为96%和87%。
要点
- 重度肥胖女性中多囊卵巢综合征(PCOS)患病率为36%,男性中肥胖相关继发性性腺功能减退症(MOSH)为64%。
- 减重手术后PCOS缓解率为96%,MOSH缓解率为87%。
- 术后女性雄激素下降并伴多毛、月经紊乱改善,男性总睾酮升高。
核心结论
- 肥胖相关gonadal功能障碍是重度肥胖患者中最常见的共病之一,应在初始诊断评估中常规排查;鉴于PCOS与MOSH均有良好缓解,作者建议对存在该障碍的重度肥胖患者提供减重手术。
研究设计与样本
- 系统综述与Meta分析,检索PubMed与EMBASE截至2016年6月的文献,最终纳入29项研究进行定量合成。
- 研究质量采用美国国家心肺血液研究所的患病率研究质量指数及无对照前后研究质量评估工具评价。
- 纳入超过10项研究的Meta分析采用漏斗图与Doi图估计发表偏倚。
主要发现
- 重度肥胖患者中PCOS患病率为36%(95CI 22-50),MOSH患病率为64%(95CI 50-77)。
- 减重手术后PCOS缓解率为96%(95CI 89-100),MOSH缓解率为87%(95CI 76-95)。
- 术后性激素结合球蛋白在女性升高22 pmol/l(95CI 2-47)、在男性升高22 pmol/l(95CI 19-26);雌二醇在女性降低-104 pmol/l(95CI -171至-39)、在男性降低-22 pmol/l(95CI -38至-7)。
- 术后总睾酮在男性升高8.1 nmol/l(95CI 6-11),在女性降低-0.7 nmol/l(95CI -0.9至-0.5)。
- 术前有多毛的女性中53%(95CI 29-76)缓解,有月经紊乱的女性中96%(95CI 88-100)缓解。
临床怎么用
- 作者认为肥胖相关gonadal功能障碍应在重度肥胖患者初始诊断评估中常规排查,并建议对存在该障碍的重度肥胖患者提供减重手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sexual dimorphism manifests noticeably in obesity-associated gonadal dysfunction. In women, obesity is associated with androgen excess disorders, mostly the polycystic ovary syndrome (PCOS), whereas androgen deficiency is frequently present in obese men in what has been termed as male obesity-associated secondary hypogonadism (MOSH). Obesity-associated gonadal dysfunction, consisting of PCOS in women and MOSH in men, is a frequent finding in patients with severe obesity and it may be ameliorated or even resolve with marked weight loss, especially after bariatric surgery. OBJECTIVE AND RATIONALE: We aimed to obtain an estimation of the prevalence of obesity-associated gonadal dysfunction among women and men presenting with severe obesity and to evaluate the response to bariatric surgery in terms of resolution and/or improvement of this condition and changes in circulating sex hormone concentrations. SEARCH METHODS: We searched PubMed and EMBASE for articles published up to June 2016. After deleting duplicates, the abstract of 757 articles were analyzed. We subsequently excluded 712 articles leaving 45 studies for full-text assessment of eligibility. Of these, 16 articles were excluded. Hence, 29 studies were included in the quantitative synthesis and in the different meta-analyses. Quality of the studies was assessed using the Quality index for prevalence studies and the Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group available from the National Heart, Lung and Blood Institute. For meta-analyses including more than 10 studies, we used funnel and Doi plots to estimate publication bias. OUTCOMES: In severely obese patients submitted to bariatric surgery, obesity-associated gonadal dysfunction was very prevalent: PCOS was present in 36% (95CI 22-50) of women and MOSH was present in 64% (95CI 50-77) of men. After bariatric surgery, resolution of PCOS was found in 96% (95CI 89-100) of affected women and resolution of MOSH occurred in 87% (95CI 76-95) of affected men. Sex hormone-binding globulin concentrations increased after bariatric surgery in women (22 pmol/l, 95CI 2-47) and in men (22 pmol/l, 95CI 19-26) and serum estradiol concentrations decreased in women (-104 pmol/l, 95CI -171 to -39) and to a lesser extent in men (-22 pmol/l, 95CI -38 to -7). On the contrary, sex-specific changes were observed in serum androgen concentrations: for example, total testosterone concentration increased in men (8.1 nmol/l, 95CI 6-11) but decreased in women (-0.7 nmol/l, 95CI -0.9 to -0.5). The latter was accompanied by resolution of hirsutism in 53% (95CI 29-76), and of menstrual dysfunction in 96% (95CI 88-100), of women showing these symptoms before surgery. WIDER IMPLICATIONS: Obesity-associated gonadal dysfunction is among the most prevalent comorbidities in patients with severe obesity and should be ruled out routinely during their initial diagnostic workup. Considering the excellent response regarding both PCOS and MOSH, bariatric surgery should be offered to severely obese patients presenting with obesity-associated gonadal dysfunction.
引用
- Escobar-Morreale HF, Santacruz E, Luque-Ramírez M, et al. Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum Reprod Update. 2017. PMID: 28486593. doi:10.1093/humupd/dmx012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。